Abstract:Background Coronary inflammation can be assessed by the changes in perivascular adipose tissue on routine coronary CT angiograms (CCTA). Fat attenuation index score (FAI Score) quantifies the degree of inflammation in each epicardial coronary artery, and adjusts for age, sex, scan technical parameters, biological and anatomical factors. Coronary inflammation assessment in a single coronary artery was previously shown to be predictive of cardiac events in the CRISP-CT study. However, the impact of inflammation in multiple coronary arteries on clinical outcome remains unclear. Purpose To evaluate the prognostic value of the number of inflamed coronary arteries with high inflammation in the risk of cardiac death, and major adverse cardiac events (MACE). Methods In a nested cohort within the Oxford Risk Factors And Non-invasive imaging (ORFAN) study, consecutive patients (n=3,393) who underwent routine clinical CCTA were followed up over a median(IQR) 7.7(6.4-9.1) years for cardiac mortality, and MACE (including myocardial infarction, new onset heart failure, cardiac mortality). FAI Score was calculated for each of the 3 epicardial coronary arteries. Results The number of inflamed arteries (FAI Score >75th centile) showed an additive impact on cardiac mortality compared with no inflamed arteries (all vessels FAI Score <25th centile), with hazard ratio 29.8 (95% CI 13.9-63.9, p<0.001) for 3 inflamed arteries, HR 20.4 (95% CI 9.4-44.7, p<0.001) for 2 inflamed arteries, and HR 13.0 (95% CI 5.9-28.8, p<0.001) for 1 inflamed artery. (Panel A) Similarly, patients with multiple inflamed arteries showed progressively higher risk for MACE (HR 7.2, 8.3 and 12.6 for 1-, 2- and 3-inflamed arteries respectively compared to patients with no inflamed artery). (Panel B) Patients with no inflamed arteries showed very low event rates for cardiac mortality and MACE. In patients with no obstructive CAD (n=2,651), similar trends were observed whereby patients with 3-inflamed arteries showed highest risk for cardiac mortality (Panel C) and MACE (Panel D), with intermediate risk for those with 1 or 2 inflamed arteries. Conclusion The number of coronary arteries with high inflammation, measured by FAI Score from routine CCTA, is associated with adverse cardiovascular events and cardiac mortality in an additive dose-response manner.

High plasma levels of fortilin are associated with cardiovascular events in patients undergoing coronary angiography

Fortilin reduces apoptosis in macrophages and promotes atherosclerosis.

Predictive Value of Plasma Fibrinogen Levels in Patients Admitted for Acute Coronary Syndrome

Importance of Fibrinolytic Activity in Patients with Coronary Artery Diseases

The association between plasma furin and cardiovascular events after acute myocardial infarction

Elevated FURIN Levels in Predicting Mortality and Cardiovascular Events in Patients with Acute Myocardial Infarction

Plasma Macrophage Migration Inhibitor Factor is Elevated in Response to Myocardial Ischemia

High-Risk Morphological and Physiological Coronary Disease Attributes As Outcome Markers after Medical Treatment and Revascularization.

Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention

High plasma levels of endosialin and cardiovascular events in patients undergoing coronary angiography

The Fibrinogen-to-Albumin Ratio Is Associated With Outcomes in Patients With Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention.

The association between fibrinogen-to-albumin ratio and adverse prognosis in patients with myocardial infarction with non-obstructive coronary arteries

Coronary plaque volume burden and composition in patients with non-hemodynamically significant coronary artery plaques and systemic inflammation

Abstract 13552: Clinical Relevance of Endogenous Tissue-plasminogen Activator in Patients With Aortic Valve Sclerosis

Association between Plasma Interleukin-27 Levels and Cardiovascular Events in Patients Undergoing Coronary Angiography

IDDF2023-ABS-0099 Fibrosis-4 Index Predicts Adverse Cardiovascular Outcomes among Patients Comorbid with MAFLD and Coronary Heart Disease

Association between high plasma levels of legumain and cardiovascular events in patients undergoing coronary angiography

Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction

Higher Noncalcified Plaque Volume Is Associated With Increased Plaque Vulnerability and Vascular Inflammation

Changes of Plasma Macrophage Migration Inhibitory Factor Level in Patients with Acute Myocardial Infarction and Its Clinical Significance

Number of inflamed coronary vessels in prediction of cardiac death and MACE among patients undergoing routine CCTA: the Oxford Risk Factors And Non-Invasive Imaging (ORFAN) Study